Pharmacist Medication Reviews for DXC Technology
Clinical medication management for your DXC claims portfolio
3 April 2026
Medication Oversight for DXC Claims Management
DXC Technology's focus on technology-enabled claims solutions extends to comprehensive medical management. Your pharmaceutical spending deserves the same level of data-driven oversight as your other claims expenditures. IMM delivers pharmacist-led medication reviews specifically designed for your DXC claims context, identifying high-cost medication patterns through evidence-based analysis, flagging potentially inappropriate prescribing, and supporting claimant functional recovery aligned with your claims strategy.
Whether your DXC claims involve workers compensation, CTP motor accident claims, life insurance, or employer liability matters, medication review adds significant value. We provide clinical oversight that optimizes your pharmaceutical spending while ensuring claimants receive evidence-based treatment supporting functional recovery and claim closure.
What Our Medication Reviews Deliver
Our pharmacist reviews examine your DXC claimant's medication profile through clinical and economic perspectives:
- Data-driven cost analysis: We identify medications where dose reduction, cessation, or lower-cost alternatives reduce your pharmaceutical spending without compromising clinical outcomes.
- Evidence-based appropriateness assessment: We assess whether medications align with contemporary clinical guidelines and whether prescribing represents evidence-based best practice.
- Systematic safety and interaction screening: We flag drug interactions, contraindications, and adverse effect risks that may increase complications and extend claims duration.
- Functional outcome analysis: We evaluate whether medications support your claimant's recovery goals or whether adjustments would accelerate functional improvement.
- Pharmacy dispensing reconciliation: We verify that documented prescriptions align with actual dispensing, identifying non-adherence or medication diversion patterns through data cross-reference.
DXC Claim Scenarios for Medication Review
Your DXC claims teams refer for review when data or patterns suggest medication optimization opportunity:
Extended High-Cost Pharmaceutical Spending
DXC claims with ongoing high medication costs beyond the acute injury phase warrant pharmacist assessment. We determine whether pharmaceutical spending reflects appropriate management or whether data-driven cost reduction is achievable without compromising recovery.
Complex Polypharmacy Without Documented Coordination
DXC claimants on multiple medications from different prescribers benefit from structured pharmacist assessment to ensure medication necessity, dose appropriateness, and interaction safety.
Long-Term Opioid or Benzodiazepine Prescribing
Extended opioid or benzodiazepine use requires careful oversight. We assess clinical justification, establish dose optimization protocols, and develop data-supported strategies for medication transition or cessation.
Lack of Functional Progress Despite Medication
DXC claimants showing minimal functional improvement despite high medication costs warrant review to assess whether medication adjustments could accelerate recovery and reduce claims duration.
Our Review Process for Your DXC Claims
We deliver thorough medication assessment aligned to your data systems and claims timelines:
1. Claims Data and Medical Record Review
We examine your DXC claim data, medical records, and treatment history to understand your claimant's injury, treatment trajectory, and functional recovery goals. This data-driven context ensures our medication assessment aligns with your claims strategy.
2. Complete Medication Profile Analysis
We examine all current medications, doses, frequencies, and interactions through evidence-based clinical guidelines. We identify appropriateness issues and cost optimization opportunities supported by contemporary medical literature.
3. Systematic Pharmacy Dispensing Verification
We cross-reference documented prescriptions against actual pharmacy dispensing records to identify non-adherence, medication diversion, or prescriber miscommunication through systematic data analysis.
4. Quantified Functional Outcome Assessment
We assess whether your claimant's medications are delivering measurable functional improvement. We quantify gains in pain reduction, mobility, work capacity, and activities of daily living to evaluate medication effectiveness.
5. Data-Supported Recommendations
We provide concise, evidence-based recommendations with supporting clinical rationale, cost projections, and expected functional outcome improvements. Reports integrate seamlessly with your DXC systems.
Expected ROI for Your DXC Portfolio
Medication reviews generate measurable returns across multiple dimensions:
| Area | Expected Benefit |
|---|---|
| Direct pharmaceutical cost reduction | 9-21% average reduction through optimization and generic substitution |
| Adverse event prevention | Reduced hospitalizations, complications, and claim reopening from medication issues |
| Functional recovery acceleration | Claimants on optimized regimens typically show improved functional trajectory |
| Claims duration reduction | Data-driven medication optimization often shortens overall claims duration |
Integration with Your DXC Platform
We understand DXC's technology-enabled approach to claims management. Our team provides clear documentation that integrates with your data systems, direct communication support with treating practitioners, and follow-up monitoring. We can provide data exports and reporting that align with your platform workflows.
Which DXC Claims Benefit Most
Medication reviews deliver highest impact for your portfolio in:
- Long-duration workers compensation and CTP claims with ongoing pharmaceutical spending
- Claims flagged by your data analytics for potential medication cost optimization
- Claims transitioning from acute medical treatment to chronic management phase
- Complex claims with polypharmacy and multiple specialist involvement
- Claims demonstrating frequent healthcare utilization patterns in your data
Conclusion
Medication management excellence directly supports DXC's data-driven claims management approach. IMM's pharmacist-led reviews ensure your pharmaceutical spending aligns with clinical necessity and functional recovery goals through evidence-based assessment. Partner with us to embed medication review excellence into your DXC claims operations and analytics.
Ready to optimize medication management for your DXC claims?
IMM delivers evidence-based pharmacist reviews tailored to your DXC platform and claims strategy. We identify data-supported cost optimization opportunities while ensuring clinical appropriateness. Contact us to discuss integration with your systems.
Request a Medication Review
